Genmab — August 2012
-
- at de tager de fleste omkostninger
-
milestones og royalty også gode
-
haha i89 du er bedre end gamle aka
-
mere robuste efter data !!
-
de kan komme på markedet meget hurtigere end de havde regnet med i monoterapi
-
!
-
Det lyder som om de står godt!
-
skyhigh intereset
-
more parties are coming in
-
very active process
-
managament are completely confident that we will close before year end
-
så er der Zalu spørgsmål?
-
spørger til Zalu nu
-
bad luck 2010
-
we just had bad luck....
-
Dahanca forsøget
-
recruitment er finished
-
DAHANGA indrulning er færdig
-
early next year data
-
expected early next year
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind